Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data

dc.contributor.authorÖzkan, Meral
dc.date.accessioned2019-07-24T13:30:19Z
dc.date.available2019-07-24T13:30:19Z
dc.date.issued2018
dc.departmentİnönü Üniversitesien_US
dc.identifier.citationÖzkan, M. (2018). Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data. Cilt:73, 46-46 ss.en_US
dc.identifier.endpage46en_US
dc.identifier.startpage46en_US
dc.identifier.urihttps://hdl.handle.net/11616/12915
dc.identifier.volume73en_US
dc.language.isoenen_US
dc.publisherPergamon-elsevıer scıence ltd, the boulevard, langford lane, kıdlıngton, oxford ox5 1gb, englanden_US
dc.relation.ispartofLeukemıa researchen_US
dc.rightsinfo:eu-repo/semantics/restrictedAccessen_US
dc.titleRetrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated dataen_US
dc.typeArticleen_US

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: